top of page

1 Sample, up to 100 Cycles
T Cell Data, Amplified

Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png
Screenshot_2024-08-01_at_1.51.38_PM-removebg-preview (1).png

Experience a leap forward in T-cell analysis with 100XBIO. Our robotic platform multiplies your data, accelerating your research and bringing new immune therapies to life faster.

Screenshot 2024-08-19 at 11.04.59 PM.png

For demonstration purposes only; actual product may vary.

Meet 100XBIO Cycler: Your partner in lab automation, designed for A-grade results.

Screenshot_2024-08-01_at_3.29_edited.png

Founder-led, Mission-driven

Led by founder Sergei Pustylnikov, PhD, we are committed to transforming R&D of T cell-mediated

therapies, empowering researchers to accelerate advancements in precision medicine.

Get in Touch

100XBIO @C2I Accelerator

299 Washington St

Woburn, MA 01801 

bottom of page